Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
28.94
-1.06 (-3.53%)
At close: Mar 3, 2026, 4:00 PM EST
28.94
0.00 (0.00%)
After-hours: Mar 3, 2026, 5:03 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Development, Manufacturing and Commercialization of Novel Therapeutics | 1.55M | 7.02M | 6.88M | 2.36M | 4.65M | | | | | |
Development, Manufacturing and Commercialization of Novel Therapeutics Growth | -77.99% | 1.99% | 192.02% | -49.32% | -37.30% | | | | | |
| 1.55M | 7.02M | 6.88M | 2.36M | 4.65M | | | | | |
| -77.99% | 1.99% | 192.02% | -49.32% | -37.30% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 1.55M | 7.02M | 6.88M | 2.36M | 4.65M | | | | | |
| -77.99% | 1.99% | 192.02% | -49.32% | -37.30% | | | | | |
| 1.55M | 7.02M | 6.88M | 2.36M | 4.65M | | | | | |
| -77.99% | 1.99% | 192.02% | -49.32% | -37.30% | | | | | |
Source: S&P Global Market Intelligence.
